Medovex Corporation to Attend BritSpine 2016 Conference

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Medovex Corporation to Attend BritSpine 2016 Conference

ATLANTA, GA--(Marketwired - Mar 30, 2016) - Medovex Corp. (NASDAQ: MDVX ), a developer of medical technology products, today announced that as part of the Company's continuing European launch planning for the DenerveX™ System, the company will be attending BritSpine 2016, the Biennial Scientific Congress of the United Kingdom Spine Societies, being held April 6 - 8, 2016, at the Nottingham Conference Center.

The BritSpine is a highly recognized scientific congress and is attended by leading spine surgeons from the UK, including The British Association of Spine Surgeons (BASS), The British Scoliosis Society (BSS), The Society for Back Pain Research (SBPR) and other leading spine surgeons around the globe. Participants will share the latest information on best practices, innovative techniques and procedures, and new technologies in spine surgery.

Medovex will attend the meeting with its UK distributor Edge Medical, Ltd., a premier distributor in surgical spine technologies. Together, they will be demonstrating the Company's DenerveX System technology for the first time to the UK Spine Societies, supported by members of our European medical advisory board and key opinion leader Dr. Vik Kapoor of Manchester, England.

The Company's patented DenerveX System, currently in final development is designed to provide longer lasting relief of pain associated with the facet joint. Lower back pain is the second most common cause of disability in the U.S. for adults. Studies indicate that 10% of the U.S. adult population suffers from lower back pain and that 31% of lower back pain is attributed to facet joint pain.

The DenerveX System consists of the DenerveX device, a single use device, and the DenerveX Pro-40 Power Generator. The DenerveX system is designed to provide a minimally invasive treatment option which combines two actions into one device.

Mr. Manfred Sablowski, Medovex Senior Vice President Sales & Marketing, stated, "We are very excited to be participating in the BritSpine 2016 and the Associated British Spine Societies, representing one of the largest spine societies in Europe. It is clearly the place to introduce new and innovative technologies, such as our DenerveX System technology as an important part of our continued strategy and preparation for a successful EU launch."

Sablowski continued, "The BritSpine 2016 is a key meeting to connect with leading spine practitioners and to collaborate and develop relationships as we continue to proceed with our product launch in the future. The event will also importantly provide us the opportunity to continue to identify leading key opinion leaders and other early adopters, as well as continue to develop strategies that we believe will help make our future launch a success and create value for our shareholders."

DenerveX is not yet CE marked or FDA cleared and is not yet commercially available.

About Medovex

Medovex was formed to acquire and develop a diversified portfolio of potentially ground breaking medical technology products. Criteria for selection include those products with potential for significant improvement in the quality of patient care combined with cost effectiveness. The Company's first pipeline product, the DenerveX device, is intended to provide long lasting relief from pain associated with facet joint syndrome at significantly less cost than currently available options. To learn more about Medovex Corp., visit www.medovex.com

Safe Harbor Statement

Certain statements in this press release constitute "forward-looking statements" within the meaning of the federal securities laws. Words such as "may," "might," "will," "should," "believe," "expect," "anticipate," "estimate," "continue," "predict," "forecast," "project," "plan," "intend" or similar expressions, or statements regarding intent, belief, or current expectations, are forward-looking statements. While the Company believes these forward-looking statements are reasonable, undue reliance should not be placed on any such forward-looking statements, which are based on information available to us on the date of this release. These forward looking statements are based upon current estimates and assumptions and are subject to various risks and uncertainties, including without limitation those set forth in the Company's filings with the Securities and Exchange Commission (the "SEC"), not limited to Risk Factors relating to its patent business contained therein. Thus, actual results could be materially different. The Company expressly disclaims any obligation to update or alter statements whether as a result of new information, future events or otherwise, except as required by law.

Medovex Corp. Jason Assad 470-505-9905 Email Contact

Scroll down for more posts ▼

Top 10 Most Recent News Articles

TIER IV Simplifies Autonomous Driving with CARLA 1.0

Updated Category News Views 63

No More Detours in Autonomous Development Ever messed with a puzzle that just won't fit until suddenly, it clicks? That's what TIER IV just pulled off with their latest work on CARLA 1.0, the open-source simulator. There's no more mucking about with that separate Python-based bridge to get things communicating—now we're talking native Autoware support. A direct line to...

Continue Reading
STORMER LAT Targets Sewer Crews' Costly Access Delays

Updated Category News Views 83

A buried cleanout can turn a simple sewer inspection into a scheduling circus. That unglamorous headache is exactly where FIBERSCOPE is aiming its new STORMER LAT Lateral Launch Camera System, announced November 17, 2026. This is not some flashy consumer gadget hunting for attention; it is field equipment built around a painfully ordinary municipal problem: crews often...

Continue Reading
Visa Direct Tests Stablecoin Prefunding in Asia-Pacific

Updated Category News Views 167

Cross-border payouts have always had an ugly little problem: money can move digitally in theory, then sit around waiting for banks to wake up in practice. Triple-A’s new collaboration with Visa Direct aims straight at that nuisance in Asia-Pacific, allowing eligible clients to use stablecoins to prefund cross-border payouts while the recipient still gets local currency....

Continue Reading
Oracle Takes AI to Construction's Messy Project Middle

Updated Category News Views 17

A stalled drywall inspection can wreck a schedule faster than any glossy AI pitch can repair it. That is the grimy, practical corner Oracle is aiming at with its latest Oracle Primavera Cloud upgrades: the daily hunt for answers, the repeated logging of familiar risks, and the finger-pointing that starts when a milestone is suddenly in danger. This is not a chatbot being...

Continue Reading
Three Cash Buyouts Draw Fresh Shareholder Scrutiny

Updated Category News Views 149

Three cash-price tags landed on the tape with a lawyerly asterisk attached: are public holders actually getting a fair shake? On November 18, 2026, Halper Sadeh LLC said it was investigating proposed sales involving Surgery Partners, Braze and CCC Intelligent Solutions. That is not a finding of misconduct, and investors ought to keep that distinction bolted firmly to the...

Continue Reading
Qonto's Banking License Raises the Stakes in Europe

Updated Category News Views 56

A regulatory stamp can look dull on paper, yet this one changes the machinery underneath Qonto. The Paris-based finance platform has received a Credit Institution license from France's ACPR and the European Central Bank, giving it a route to offer broader lending and savings products directly to small and midsize businesses across Europe. That is a serious corporate...

Continue Reading
Luxury's €1.5 Trillion Market Has Moved to Memories

Updated Category News Views 36

A €1.5 trillion market that cannot grow much is still a market worth fighting over, but luxury's old playbook is looking awfully tired. Bain's 2026 view is for global luxury spending to land somewhere between flat and up 2% at constant exchange rates versus 2025. That is stability, not a victory parade. Yet the total market remains 16% to 22% above 2019 levels, and the...

Continue Reading
Vusion's 2030 Plan Puts Recurring Revenue First At Scale

Updated Category News Views 30

Shelf labels are not exactly romance, yet Vusion has turned them into a serious growth machine. The 2030 plan is not really about hanging more electronic displays in aisles; it is about making those displays, sensors and store connections produce software and service revenue for years. That is the part of this story worth watching. The Hardware Base Is Becoming the Hook...

Continue Reading
Clorox Boosts Payout With Steady $1.25 Dividend

Updated Category News Views 205

Quarterly Dividends: A Clorox Tradition It seems you can't talk about Clorox (NYSE: CLX) without mentioning its steadfast dedication to shareholders. Once again, this 113-year-old stalwart is back on the map with its juicy quarterly dividend—$1.25 per share, to be precise. That's scheduled to hit your account by February 12, 2027, if you're on the books by the end of...

Continue Reading
Visual Cipher Bench Exposes AI Agents' Hidden Rule Gap

Updated Category News Views 0

Forty little black-and-white puzzles just threw a bucket of cold water on the autonomous-agent sales pitch. Einsia AI’s Navers Lab says its new Visual Cipher Bench found that the best result among eight frontier models was only 26.7%, with no tested configuration clearing 30%. That is not a minor blemish. It is a reminder that a model can sound clever, use tools, and...

Continue Reading

Top 5 Most Recently Viewed Articles

Class Action Alert: KBR, Inc. Investors Should Take Note

Updated Category News Views 351

Class Action Alert for KBR, Inc. Investors Attention to all stakeholders of KBR, Inc. (NYSE: KBR): there has been significant news affecting your investments. A class action lawsuit is underway, compelling shareholders to reflect on the recent allegations against the company. Amidst claims of misleading communications concerning a crucial contract, KBR's stock has been...

Continue Reading
PyroGenesis Reports Q3 2025 Performance and Future Outlook

Updated Category News Views 192

Financial Insights from PyroGenesis' Q3 2025 PyroGenesis Inc. (TSX:PYR), a frontrunner in plasma-based technologies for heavy industry and defense, has unveiled its financial and operational results for the third quarter of 2025. This report highlights a revenue of $3.25 million, which reflects an 18.7% decline from the same period last year. This downturn is attributed...

Continue Reading
Metacon Reports Remarkable Revenue Growth in Q1 2025

Updated Category News Views 443

Metacon Achieves Significant Financial Milestones in Q1 2025 The first quarter of 2025 has marked an exciting chapter for Metacon, showcasing remarkable progress both financially and operationally. During this period, the company realized net sales of SEK 50 million, a substantial increase compared to SEK 8.3 million in the same quarter last year. This remarkable growth...

Continue Reading
Revolutionizing Workplace Productivity with Humanyze Insights

Updated Category News Views 106

Transforming the Workforce with AI-Driven Insights Humanyze, a pioneer in workforce analytics, recently unveiled Humanyze Insights, a cutting-edge platform specifically designed to enhance workforce productivity, drive profitability, and inspire sustainable growth for organizations. This AI-powered solution signifies a notable evolution from Humanyze’s previous...

Continue Reading
SKE Invigorates IRONWORKS London's Music Vibe With E-Cigs

Updated Category News Views 646

Bringing SKE's Flair to London's Music Scene Well, folks, hold onto your hats—SKE's thrown its weight behind IRONWORKS London, extending its reach deeper into the UK's electronic music scene. This ain't just another gig; we're talking about the second time SKE is flexing its sponsorship muscles in the UK music arena, officially angling for the vape category spotlight....

Continue Reading